Masao Hashimoto

7PUBLICATIONS

51CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 15, 2026

Simultaneous TCR and IL-2 agonism selectively enhances epitope-specific CD8 T-cell responses during chronic viral infection.

|Jan 08, 2025

An early precursor CD8<sup>+</sup> T cell that adapts to acute or chronic viral infection.

Daniel T McManus, Rajesh M Valanparambil, Christopher B Medina

|Nov 22, 2023

Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.

Annapaola Mariniello, Tahseen H Nasti, Daniel Y Chang

|Aug 25, 2023

PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.

Amanda L Gill, Peter H Wang, Judong Lee

|Apr 07, 2023

Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibition.

Laura Codarri Deak, Masao Hashimoto, Pablo Umaña

|Sep 28, 2022

PD-1 combination therapy with IL-2 modifies CD8<sup>+</sup> T cell exhaustion program.

Masao Hashimoto, Koichi Araki, Maria A Cardenas

Pageof 2

Frequent Collaborators

Rafi Ahmed

Judong Lee

Haydn T Kissick

Pablo Umaña

Gordon J Freeman

Andreas Wieland

Christian Klein

Maria A Cardenas

Christopher D Scharer

2 joint publications

William H Hudson

Frequent Collaborators

Rafi Ahmed

Judong Lee

Haydn T Kissick

Pablo Umaña